New Horizons - A White Paper: Navigating the Human Frontier of AI Adoption in Pharma

© Redbow Consulting Group 2026, All rights reserved New Horizons - A White Paper : Navigating the Human Frontier of AI Adoption in Pharma: Leadership, Culture, and Strategy in 2026 by Jonathan Dancer, MBA As we move deeper into the era of artificial intelligence (AI) , it has become evident that this revolution transcends pure technology. The technical capabilities of new models are clearly advancing at a breakneck pace; however, what remains most intricate and pivotal are those things that revolve around the human domain. This White Paper explores the adoption of AI in P harmaceutical s, specifically its commercial functions through a human rather than technology lens and the author has triangulated the findings with external cross - industry reports by Bain & Company , IBM’s Institute for Business Value, McKinsey, Deloitte, PwC, Capgemini, and the World Economic Forum. The work derives from a series of in - depth interviews with industry leaders conducted in April 2026 by the author , and b eyond detailing its qualitative findings, the report seeks to align these insights with prevailing themes in the general field of AI adoption . The outcome is a comprehensive reflection on how leadership vision, culture, governance, and workforce transformation are collectively shap ing the trajectory and value of AI within pharmaceutical organisations. It explores the themes of leadership vision, organisational culture, trust, governance, human factors, workforce transformation, and workflow embedding as critical vectors for capturing AI’s value and attempts to draw conclusions and recommendations . 1. From Leadership Sponsorship to Strategic CEO - Led Agentic AI Transformation Findings The successful adoption of AI in Pharma is inextricably linked to the vision and culture set by leadership. Insights from interviews underscore that companies progressing steadily with AI initiatives share a common denominator: robust sponsorship from top executives, particularly CEOs and CIOs. This leadership backing is more than symbolic; it acts as the driving catalytic force that shapes the very character of AI adoption efforts. Distinct leadership styles influence the approach to AI deployment — ranging from cautious, incremental adjustments to dynamic transformations that welcome experimentation and a “fail fast” attitude that tolerate s or even encourages failure. A respondent noted, “The CEO... pushed for us to really engage in leading [AI adoption ] , and it changed the culture a lot.” In the interviews , s uch commitment correlate d with companies fostering a culture that either embrace d structured governance with formalised training or promote d a trial - and - error ethos, empowering individuals to explore AI’s potential. Critically, leaders who frame AI as an augmentation — supporting rather than threatening existing roles — help to dissipate anxieties around job displacement. When this perspective is absent, scepticism and mistrust deepen. One interviewee observed, “The company about ‘AI is not going to take your job. [It’s about] t he person who’s going to take your job is somebody who knows how to use AI.’” This messaging is pivotal to fostering acceptance and encouraging proactive adoption rather than resistance. Interestingly, approaches vary significantly between organisations, perhaps shaped by cultural norms, leadership philosophies, or technological maturity. Some C Suites almost seemed to be falling over themselves to get on the “ AI travellator ” with a terrific sense of urgency or competition, where senior leaders are keen to position AI as a core competency or seeking a hallmark of being in the upper innovation quartile. “There was no clear roadmap, but a lot of buzz from senior people.”